Endocardial Mapping With the CoreMap EP Mapping System
ConditionPersistent Atrial Fibrillation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorCoreMap Inc.
About this trial
This is a global, multi-site, prospective, feasibility study.
Eligibility criteria
Qualifiers
Subject has persistent or long-standing persistent AF, at the discretion of the investigator (Phase 1 & 2)
Subject has PerAF with no history of prior AF ablation therapy (Phase 3)
Subject is 18 to 80 years of age
Subject has presence of AF-related symptoms and is scheduled for clinically indicated standard of care AF ablation to manage PerAF (Phase 2 or 3) or long-standing PerAF (Phase 2)
Disqualifiers
Myocardial infarction (MI)
Any surgical or percutaneous cardiac procedure including coronary intervention and cardiac ablation
Confirmed thrombus on imaging
Cardiac surgery including coronary artery bypass grafting, ventriculotomy, atriotomy
Trial design
Treatments tested in this trial
- CoreMap EP Mapping System Mapping
- CoreMap EP Mapping System Map-Guided Ablation
Treatment groups
245 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov